New treatment for Parkinson's disease

 Parkinson's Treatment Hue Light USA New York

Parkinson's disease is not a very rare disease. Given the incidence of 0.01 percent, and the fact that this Parkinson's population is mainly distributed among the elderly, you can pass by people with Parkinson's disease several times a day.

Parkinson's disease is a neurodegenerative disease, and it refers to a disease in which the width of movement is reduced and slowed down, symptoms such as trembling in the hands or legs appear, and muscle movement is reduced. Although modern medicine has developed a lot, it is a disease that many patients with Parkinson's disease and their families are suffering from because a method or treatment method that can completely return to the state before the onset of Parkinson's disease has not yet been developed.

But little by little, a light of hope is shining in this Parkinson's disease, which seemed to have no end in sight. In fact, a patient who received systemic PBM therapy periodically at Hue Light USA New York Center revealed that her Parkinson's disease was significantly improved after systemic PBM therapy.

In her video, she confessed that she is a Parkinson's disease category 2 patient, and that she had stopped taking her medicine for about 3 days after the systemic PBM therapy, and she experienced great relief in her pathological movement limitations. I did. The reason she was able to see the improvement in her Parkinson's disease was because of systemic PBM therapy. Systemic PBM therapy, also called photobiomodulation therapy, is already actively used in the United States and Europe, and several studies have proven that it has a beneficial effect on improving symptoms and treating Parkinson's disease.

In particular, the main theory is that there is no doubt that misfolding, aggregation, and fibrosis of α-synuclein (α-synuclein), which are the main symptoms of Parkinson's disease, are central to the pathogenesis of Parkinson's disease. If the main cause of Parkinson's disease is prevented, it can be reversed.

When alpha-synuclein keeps accumulating in nerve cells, the cells die. It starts in the brainstem at first, and later gradually rises to the substantia nigra of the midbrain. And when more than 50 percent of the brain cells in the substantia nigra are destroyed, symptoms such as hand tremor, slow movement, and narrowing of movement appear, which are common symptoms of Parkinson's disease. In particular, this substantia nigra is a disease that produces dopamine. And dopamine is also one of the main causes of Parkinson's disease. This is because when dopamine production is lowered to less than 70%, motor symptoms caused by Parkinson's disease appear or worsen. If left unattended, the symptoms may become so severe that even a simple walking motion is difficult to perform alone.

Therefore, if you have been diagnosed with Parkinson's disease, you need to be careful with the administration of dopamine and alpha-synuclein. But that doesn't mean we can arbitrarily control the release of dopamine at home or prevent alpha-synuclein from building up. That's why we get outside help.

As the Parkinson's disease patient is talking about in the video, the effectiveness of systemic PBM therapy has recently been proven at a Parkinson's specialty hospital in Korea (Seocho-dong).

In 2016, in a monkey animal test with Parkinson's disease, the majority of monkeys were observed to improve. Systemic PBM therapy is characterized by no side effects unlike drugs.

Since systemic PBM therapy is non-pharmacological, there is no need to worry about side effects, and since it uses relatively low power density, it does not place any special burden on the body. At the same time, it prevents the dopamine-producing neurons located in the substantia nigra, which is very deep in the brain, from degenerating, so it can slow down the deterioration and progression of Parkinson's disease.

Then why does it have to be systemic PBM therapy? Of course, PBM therapy can be performed only in one local area. For example, you can only irradiate light on the head. However, doing so will not give us the results we want. Since the symptoms of Parkinson's disease appear throughout the body, more efficient and effective changes can be expected when PBM therapy is also performed throughout the body. It can also help with insomnia, indigestion, inflammatory diseases, immune diseases, peripheral neuropathy, and various pains that can easily occur. In particular, patients with Parkinson's disease are often exposed to mental health diseases such as depression and anxiety due to a large elderly population and a significant decline in quality of life after onset. Systemic PBM therapy can also help in these areas.

Hue Light’s whole-body PBM Chamber